A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The ...

The latest update is out from Intelligent Bio Solutions ( (INBS) ).

Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its ...

Background The increasing number of patients treated by long-term non-invasive ventilation (NIV) challenges the capacity of ...

Scientists and clinicians reported advances that addressed conditions once thought irreversible, from congenital deafness and ...

At King Faisal Specialist Hospital & Research Centre (KFSHRC), the treatment of drug-resistant epilepsy has developed over decades into a comprehensive clinical program that combines advanced ...

Syrma Johari’s leadership shared a similar sentiment, noting that the partnership reflects a strong alignment in innovation, quality, and long-term vision, and that it is pleased to support INBS in ...

A four–amino acid peptide called CAQK has shown powerful brain-protective effects in animal models of traumatic brain injury. Delivered through a standard IV, it zeroes in on injured brain tissue, ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

Exosome-based treatment for GBM has received FDA orphan drug designation, indicating its potential in treating this aggressive CNS tumor. Exousia AI's technology uses exosomes to deliver therapeutics ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...